Abstract
Peptides represent the largest class of biologically active ligand that exist within central nervous system (CNS) neurons and their axonal projections. The physiologic role that these peptides play in the regulation of brain cellular functions, including neurotransmission, has not been determined. Most brain peptides display biological actions when administered into the CNS, thus leading to hypotheses regarding their physiologic roles. In addition to characterization of the physiologic roles of these peptides within the CNS, it is evident that these substances may be utilized as neurochemical probes with unique specificities for select neuronal populations to study both cellular and integrated CNS functions. An area of importance to physiologists has been the use of peptides to modify brain neuroendocrine and autonomic nervous system neuro-humoral effector mechanisms that regulate visceral organ function. This chapter will describe some of the CNS peptides that may be used as probes to study neuroendocrine and autonomic control of glucose metabolism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
C. L. Lee and R. E. Miller, The hepatic vagus nerve and the neural regulation of insulin secretion, Endocrinol. 117:307 (1985).
A. Niijima, Glucose-sensitive afferent nerve fibers in the hepatic branch of the vagus nerve in the guinea pig, J. Physiol. 332:315 (1982).
O. Yutaka and H. Yoshimatsu, Neural network of glucose monitoring system, J. Auton. Nerv. Syst. 10:359 (1984) .
B. R. Landau, Y. Takaoka, M. A. Abrams, S. M. Genuth, M. Van Houten, B. I. Posner, R. J. White, S. Ohgaku, A. Horvat, and E. Hemmelgarn, Binding of insulin by monkey and pig hypothalamus, Diabetes 32:284 (1983).
B. E. Dunning, J. H. Moltz, and C. P. Fawcett, Actions of neurohypophyseal peptides on pancreatic hormone release, Amer. J. Physiol. 246:E108 (1984).
E. Bobbioni and B. Jeanrenaud, A rat hypothalamic extract enhances insulin secretion in vitro, Endocrinol. 113:1958 (1983).
L. J. Grimes, C. Mok, and J. M. Martin, Effect of a bovine hypothalamic extract on glucose utilization by rat adipocytes, Amer. J. Physiol. 234:E554 (1978) .
L. A. Idahl and J. M. Martin, Stimulation of insulin release by a ventrolateral hypothalamic factor. J. Endocr. 51:601 (1971).
G. A. Taborsky and D. Porte, Jr., Stress-induced hyperglycemia, in: “The Neurobiology and Neuro-endocrinology of Stress,” M. R. Brown, C. Rivier, and G. Koob, eds., Marcel Dekker, Inc., New York (in press).
J. Pernow, J. Schwieler, T. Kahan, P. Hjemdahl, J. Oberle, B. G. Wallin, and J. M. Lundberg, Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release, Amer. J. Physiol. 257: H866 (1989).
J. M. Lundberg, B. Hamberger, M. Schultzberg, T. Hokfelt, P-O Granberg, S. Efendic, L. Terenius, M. Goldstein, and R. Luft, Enkephalin-and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma, Proc. Natl. Acad. Sci. USA 76:4079 (1979).
G Terenghi, J. M. Polak, I. M. Varndell, Y. C. Lee, J. Wharton, and S. R. Bloom, Neurotensin-like immunoreactivity in a subpopulation of noradrenaline-containing cells of the cat adrenal gland, Endocrinol. 112:226 (1983).
R. Corder, D. F. J. Mason, D. Perrett, P. J. Lowry, V. Clement-Jones, E. A. Linton, G. M. Besser, and L. H. Rees, Simultaneous release of neurotensin, somatostatin, enkephalins and catecholamines from perfused cat adrenal glands, Neuropeptides 3:9 (1982) .
L. W. Swanson and P. E. Sawchenko, Hypothalamic integration: organization of the paraventricular and supraoptic nuclei, Ann. Rev. Neurosci. 6: 269 (1982) .
M. R. Brown, M. Mortrud, R. Crum, and P. Sawchenko, Role of somatostatin in the regulation of vasopressin secretion, Brain Res. 452:212 (1988).
M. R. Brown, R. Crum, and P. Sawchenko, Somatostatin-28 (SS-28) stimulation of vasopressin (AVP) and oxytocin (OT) secretion, Endocrinol. 122(Suppl.): 660 (1988).
C. D. Sladek, Regulation of vasopressin release by neurotransmitters, neuropeptides and osmotic stimuli, Prog. Brain Res. 60:71 (1983).
S. Amir and P. D. Butler, Thyrotropin-releasing hormone blocks neurally-mediated hyperglycemia through central action, Peptides 9:31 (1988).
M. R. Brown, Thyrotropin releasing factor: a putative CNS regulator of autonomic nervous system outflow, Life Sci. 28:1789 (1981).
M. R. Brown, L. A. Fisher, J. Spiess, J. Rivier, C. Rivier, and W. Vale, Corticotropin-releasing factor (CRF): actions on the sympathetic nervous system and metabolism, Endocrinol. 111:928 (1982).
J. E. Morley and A. S. Levine, Intraventricular cholecystokinin octapeptide produces hyperglycemia in rats,Life Sci. 28:2187 (1981).
A. Iguchi, H. Matsunaga, T. Nomura, M. Gotoh, and N. Sakamoto, Glucoregulatory effects of intrahypothalamic injections of bombsin and other peptides, Endocrinol. 114:2242 (1984).
M. Brown, Y. Tache, and D. Fisher, Central nervous system action of bombesin: mechanism to induce hyperglycemia, Endocrinol. 105:660 (1979).
J. M. Overton and L. A. Fisher, Modulations of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides, Brain Res.488:233 (1989).
N. A. Scott, V. Webb, J. H. Boublik, J. Rivier, and M. R. Brown, The cardiovascular actions of centrally administered neuropeptide Y, Regul. Peptides 25:247 (1989) .
H. Somiya and T. Tonoue, Neuropeptides as central integrators of autonomic nerve activity: effects of TRH, SRIF, VIP and bombesin on gastric and adrenal nerves, Regul. Peptides 9:47 (1984).
M. R. Brown, K. Carver, and L.A. Fisher. Bombesin: central nervous system actions to affect the autonomic nervous system, in: “Annals of the New York Academy of Sciences, Vol. 547, Bombesin-like Peptides in Health and Disease,” Y. Tache, P. Melchiorri, and L. Negri, eds., New York Academy of Sciences, New York (1989).
G. R. Van Loon, N. M. Appel, and D. Ho, Endorphin-induced stimulation of central sympathetic outflow: endorphin increases plasma concentrations of epinephrine, norepinephrine, and dopamine in rats, Endocrinol. 109:46 (1981).
M. R. Brown, L. A. Fisher, V. Webb, W. W. Vale, and J. E. Rivier, Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion, Brain Res. 328:355 (1985).
D. A. Fisher and M. Brown, Somatostatin analog: plasma catecholamine suppression mediated by the central nervous system, Endocrinol. 107:714 (1980).
M. R. Brown and L. A. Fisher, Brain peptide regulation of adrenal epinephrine secretion, Amer. J. Physiol.247:E41 (1984).
M. R. Brown, J. Rivier, and W. Vale, Somatostatin: central nervous system actions on glucoregulation, Endocrinol. 104:1709 (1979).
M. R. Brown and L. A. Fisher, Corticotropin releasing factor: effects on the autonomic nervous system and visceral systems, Fed. Proc. 44:243 (1985).
C. Rivier and W. Vale, Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function, Fed. Proc. 44: 189 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Brown, M.R. (1991). Use of Peptide Probes to Study Brain Regulation of Glucose Metabolism. In: Vranic, M., Efendic, S., Hollenberg, C.H. (eds) Fuel Homeostasis and the Nervous System. Advances in Experimental Medicine and Biology, vol 291. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5931-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5931-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5933-3
Online ISBN: 978-1-4684-5931-9
eBook Packages: Springer Book Archive